DrugPatentWatch Database Preview
Drugs in Development Information for Deoxythymidine
What is the development status for investigational drug Deoxythymidine?
Deoxythymidine is an investigational drug.
There have been 8 clinical trials for Deoxythymidine.
The most recent clinical trial was a Phase 2 trial.
The most common disease conditions in clinical trials are HIV Infections, Infection, and Communicable Diseases. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), Bristol-Myers Squibb, and Vall d'Hebron Research Institute.
Summary for Deoxythymidine
US Patents | 0 |
International Patents | 0 |
US Patent Applications | 4,206 |
WIPO Patent Applications | 2,804 |
Japanese Patent Applications | 4 |
Clinical Trial Progress | Phase 2 (1969-12-31) |
Vendors | 79 |
Recent Clinical Trials for Deoxythymidine
Title | Sponsor | Phase |
---|---|---|
An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 | Modis Therapeutics, Inc. | Phase 2 |
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine | Centro de Investigación Biomédica en Red Enfermedades Raras (CIBERER), Spain | Phase 1/Phase 2 |
Treatment of TK2 Deficiency With Thymidine and Deoxycytidine | Hospital Universitario 12 de Octubre | Phase 1/Phase 2 |
Clinical Trial Summary for Deoxythymidine
Top disease conditions for Deoxythymidine
Top clinical trial sponsors for Deoxythymidine
US Patents for Deoxythymidine
Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
---|---|---|---|---|
>Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |